FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation.

Andrea Wangorsch, Christian J Buchholz, Klaus Cichutek, Ben Berkhout, Elena Herrera-Carrillo, Andreas Greinacher, Jessica Hartmann, Alexander O Pasternak, Andreas Reuter, Vanessa Riechert, Arezoo Jamali, Samuel A Theuerkauf, Philipp A Adams, Jan Wesche, Mathias Zimmermann, Mayken Visser, Sascha Hein

Journal: The Journal of biological chemistry 2023;299(6):104743

PMID: 37100283

Abstract

Fc receptors are involved in a variety of physiologically and disease-relevant responses. Among them, FcγRIIA (CD32a) is known for its activating functions in pathogen recognition and platelet biology, and, as potential marker of T lymphocytes latently infected with HIV-1. The latter has not been without controversy due to technical challenges complicated by T-B cell conjugates and trogocytosis as well as a lack of antibodies distinguishing between the closely related isoforms of FcγRII. To generate high-affinity binders specific for FcγRIIA, libraries of designed ankyrin repeat proteins (DARPins) were screened for binding to its extracellular domains by ribosomal display. Counterselection against FcγRIIB eliminated binders cross-reacting with both isoforms. The identified DARPins bound FcγRIIA with no detectable binding for FcγRIIB. Their affinities for FcγRIIA were in the low nanomolar range and could be enhanced by cleavage of the His-tag and dimerization. Interestingly, complex formation between DARPin and FcγRIIA followed a two-state reaction model, and discrimination from FcγRIIB was based on a single amino acid residue. In flow cytometry, DARPin F11 detected FcγRIIA cells even when they made up less than 1% of the cell population. Image stream analysis of primary human blood cells confirmed that F11 caused dim but reliable cell surface staining of a small subpopulation of T lymphocytes. When incubated with platelets, F11 inhibited their aggregation equally efficient as antibodies unable to discriminate between both FcγRII isoforms. The selected DARPins are unique novel tools for platelet aggregation studies as well as the role of FcγRIIA for the latent HIV-1 reservoir.

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Address: Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany.; Division of Virology, Paul-Ehrlich-Institut, Langen, Germany.; Division of Haematology and Transfusion Medicine, Paul-Ehrlich-Institut, Langen, Germany.; Institute for Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.; Division of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.; Department of Molecular Allergology, Paul-Ehrlich-Institut, Langen, Germany.; Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany.; Department of Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.